On May 11, the Government of Alberta passed amendments to the Scheduled Drugs Regulation designating “Naloxone and its salts for use in emergency treatment of opioid overdose outside of hospital” as a Schedule 2 drug. This change took effect as of Friday, May 13, 2016.
To support our professions, ACP provided pharmacists and pharmacy technicians with guidance to comply with ACP’s Code of Ethics and Standards of Practice for dispensing or selling Naloxone as a Schedule 2 drug.
ACP’s guidance document can be accessed on our website’s resource centre under tools and guidelines, or by clicking here. For information on billing and compensation for THN kits, please refer to the Alberta Blue Cross Benefact.
Pharmacists play an integral role in the delivery of care to Alberta’s vulnerable populations, and are encouraged to participate in the Naloxone Program.
